Scarica l'app Stockscreener
4.57
1.56%
0.07
Pre-mercato:
4.57
Precedente Chiudi:
$4.50
Aprire:
$4.54
Volume 24 ore:
1.10M
Relative Volume:
0.94
Capitalizzazione di mercato:
$405.25M
Reddito:
$73.48M
Utile/perdita netta:
$-108.30M
Rapporto P/E:
-2.0311
EPS:
-2.25
Flusso di cassa netto:
$-67.17M
1 W Prestazione:
-18.97%
1M Prestazione:
-28.26%
6M Prestazione:
-1.93%
1 anno Prestazione:
+6.03%
Intervallo 1D:
$4.515
$4.72
Intervallo di 1 settimana:
$3.84
$4.72
Portata 52W:
$2.8262
$7.79
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Confronta PSNL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
4.57 | 399.05M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
477.41 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.72 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.27 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
117.32 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.91 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
Personalis Inc. Crosses 200 Day MA — Signal or NoiseFast Return Equity Trade Forecast Points to Small Caps - 선데이타임즈
Does Personalis Inc. have declining or rising EPSMassive Potential Swing Trades - thegnnews.com
After Plunging 30.5% in 4 Weeks, Here's Why the Trend Might Reverse for Personalis (PSNL) - Yahoo Finance
Craig-Hallum Analyst Maintains Buy Rating on Personalis with $7 Price Target - AInvest
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN
These Analysts Think Personalis, Inc.'s (NASDAQ:PSNL) Sales Are Under Threat - simplywall.st
Personalis outlines $70M–$80M revenue target for 2025 amid 59% sequential clinical test growth and revised biopharma outlook - MSN
All You Need to Know About Personalis (PSNL) Rating Upgrade to Buy - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - uk.finance.yahoo.com
HC Wainwright & Co. Maintains Buy Rating on Personalis, Lowers Price Target to $8.50 - AInvest
Personalis, Inc. shares fall 1.03% after-hours following a securities lawsuit against Tempus AI, Inc. - AInvest
A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $6 to $9 - 富途牛牛
Personalis Reports Q2 2025 Financial Results - The Globe and Mail
Personalis Earnings Call: Growth Amidst Financial Challenges - TipRanks
Personalis (PSNL) Q2 Revenue Falls 24% - AOL.com
PSNL: HC Wainwright & Co. Lowers Target Price, Maintains Buy Rat - GuruFocus
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - 富途牛牛
Personalis 2025 Q2 Earnings Sustained Losses Despite Sequential Clinical Growth - AInvest
Personalis: Strong Molecular Testing Growth and Strategic MRD Focus Support Buy Rating - TipRanks
Personalis Plunges 26.06% on Revenue Targets - AInvest
Personalis: Q2 Earnings Snapshot - Huron Daily Tribune
Personalis (PSNL) Q2 Revenue Falls 24% - The Motley Fool
Personalis (PSNL): Navigating Near-Term Headwinds, Positioning for MRD Market Domination - AInvest
Personalis' Q2 2025 Earnings Call: Dissecting Contradictions in Revenue Projections and Reimbursement Strategies - AInvest
Personalis Sees 59% Sequential Clinical Test Growth, Targets $70M-$80M in Revenue for 2025 - AInvest
Earnings call transcript: Personalis Q2 2025 reveals revenue miss, stock steady - Investing.com Canada
Personalis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Personalis Inc. Q2 Financial Performance ReportNews and Statistics - IndexBox
PSNL Predicts Modest Revenue Growth in Q3 - GuruFocus
PERSONALIS Earnings Results: $PSNL Reports Quarterly Earnings - Quiver Quantitative
Personalis earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Healthcare firm Personalis' Q2 revenue misses estimates - MarketScreener
Personalis reports Q2 EPS (23c), consensus (24c) - TipRanks
Personalis Reports Second Quarter 2025 Financial Results - Yahoo Finance
What are analysts’ price targets for Personalis Inc. in the next 12 monthsNavigate the market with precision tools - Jammu Links News
How does Personalis Inc. compare to its industry peersInvest confidently with real-time updates - Jammu Links News
What drives Personalis Inc. stock priceGet alerts on the hottest stocks daily - Jammu Links News
How strong is Personalis Inc. company’s balance sheetRobust financial gains - Jammu Links News
What are the technical indicators suggesting about Personalis Inc.Unmatched profit growth - Jammu Links News
Is Personalis (NASDAQ:PSNL) Using Too Much Debt? - 富途牛牛
Personalis, Inc. (NASDAQ:PSNL) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing - simplywall.st
What makes Personalis Inc. stock price move sharplyFree Alert Feed for Momentum Based Picks - Newser
Top Risks to Consider Before Buying Personalis Inc. StockTrading Watchlist with Real Time Filters - Newser
Assembly Biosciences (NASDAQ:ASMB) & Personalis (NASDAQ:PSNL) Head-To-Head Contrast - Defense World
Does Personalis Inc. show high probability of reboundFree Low Risk High Return Opportunities - Newser
Key metrics from Personalis Inc.’s quarterly dataWatchlist Summary for Active Day Traders - Newser
News impact scoring models applied to Personalis Inc.Free High Conviction Intraday Stock Signals - Newser
What catalysts could drive Personalis Inc. stock higher in 2025Pre Market Review For Consistent Profits - Jammu Links News
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):